PREVENTING MEDICATION ERRORS IN PHARMACY PRACTICE DR. SULLIVAN S SUPPLEMENTAL HANDOUT



Similar documents
A REVIEW OF FEDERAL PHARMACY LAW DONALD SULLIVAN, PH.D

BE WISE, IMMUNIZE: AN UPDATE ON IMMUNIZATION PRACTICES GRETCHEN KRECKEL GAROFOLI, PHARMD

OVERVIEW OF RECENT PHARMACY LAW CASES DAVID BRUSHWOOD, JD, RPH

REVIEW OF FEDERAL LAW FOR PHARMACY TECHNICIANS DR. SULLIVAN S MONOGRAPH

PRS 103 CONTEMPORARY ISSUES IN PHARMACY REGULATION PRS 103.6: LICENSURE AS ASSURANCE OF COMPETENCE DR. BRUSHWOOD S MONOGRAPH

WHEN THE STARS ALIGN AND YOUR PATIENT IS IN SYNC: ADHERENCE RISES MARK GAROFOLI, PHARMD, MBA, CGP PETE KRECKEL, RPH

DEFENDING A FEDERAL CRIMINAL CHARGE AND A BOARD ACTION ROBERT ESGRO, RPH, ESQ

MOVEMENT BEYOND LAXATIVES: EVOLVING PHARMACOLOGIC OPTIONS FOR IBS-C AND CIC PETE KRECKEL, RPH

PRS 101 FOUNDATIONS OF PHARMACY REGULATION PRS 101.3: THE DRUG ENFORCEMENT ADMINISTRATION REGULATORY ROLE DR. BRUSHWOOD S MONOGRAPH

SHOULD WE ALL TAKE OMEGA-3 FATTY ACID SUPPLEMENTS? GENEVA BRIGGS, PHARMD, BCPS

RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE JOHNATHON DUFTON, MD

ON PENS AND NEEDLES A PRIMER ON INSULIN PENS AND PROPER INJECTION TECHNIQUES PETE KRECKEL, RPH

A FOCUS ON TOPICS IN OHIO PHARMACY LAW -- OHIO STATE BOARD OF PHARMACY APPROVED DR. SULLIVAN S MONOGRAPH

TESTOSTERONE REPLACEMENT THERAPY FOR THE AGING MALE: COUNSELING INSIGHTS FOR THE PHARMACIST TIM DRAKE, PHARM.D.

ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO SGLT2 INHIBITORS PETER A. KRECKEL, R.PH.

ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS LAUREN HYNICKA, PHARM.D.

MEMBER S CHOICE: THE REQUESTED SPANISH PHRASES FOR THE PHARMACY STEPHANIE LANGSTON, MFLE

UNDERSTANDING AND TREATING ADHD TAMMIE LEE DEMLER, PHARMD, MBA, BCPP

Overview of Recent Pharmacy Law Cases

Mood Disorders in PD: What s New?

PTSD 101: 2010 VA/DoD Clinical Practice Guideline for PTSD: Anger, Aggression, and PTSD

Responsible Conduct of Research (RCR)

Power Thinking for the Perioperative Nurse

Veterans Health Administration Employee Education System. And. VACO Office of Quality and Safety, Evidenced Based Practice And

116th Annual Convention

How To Accredit A Continuing Education Program

Target Audience VHA/DoD physicians, nurses, pharmacists, and dieticians involved in the care of patients with chronic kidney disease.

International Transplant Nurses Society Speaker / Planner Bio Form

Professor, Pharmacy Practice, Ohio Northern University, College of Pharmacy Business Law

Drug-Supplement Interactions Course #15-102

University of South Florida College of Nursing

CONTINUING EDUCATION REQUIREMENTS FOR MICHIGAN PHARMACY TECHNICIANS

UNDERSTANDING THE HIGH-TOUCH MODEL: GETTING ACQUAINTED WITH SPECIALTY PHARMACY DR. MCPHERSON S MONOGRAPH

MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act.

Public Health and Preventive Medicine Webinars and Training

Professional Education Summit Emerging Trends in Diabetes Care Saturday, October 17, :00 am 4:00 pm* EvergreenHealth Medical Center Kirkland, WA

Multiple Sclerosis in Practice. An Expert Commentary With Jeffrey Cohen, MD, PhD A Clinical Context Report

The New Pharmacology for Medical Careers

DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY TECHNICIANS. Filed with the Secretary of State on

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act.

2016 PTEC Conference Schedule

Category 2 credit will be awarded for formal educational programs that are ACCME-accredited or AAFPapproved

Health Literacy & Medication Safety

June G. Javier, PharmD, BCPS Friday, April 17, 2015

Guide to CE Navigation and Frequently Asked Questions (FAQs)

P.L.2015, CHAPTER 179, approved January 11, 2016 Senate, No (First Reprint)

COURSE OUTLINE. PROGRAM: Pharmacy Technician Bridging Education Program. COURSE NAME: Management of Drug Distribution. COURSE DURATION: 39 hrs.

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS TABLE OF CONTENTS

247 CMR: BOARD OF REGISTRATION IN PHARMACY

Pharmacist Emergency Responders for Cardiac Arrest and Other Medical Emergencies Practice Based Program 16 Contact Hours

How to Become a Pharmacist. Job Description. Work Environment. Career Outlook. Income

8/5/2015. Magon Saunders. Apophia Namageyo-Funa. Leslie Kolb. Jo Ellen Condon. DHSc, MS, RDN, LD. Program Development Consultant

7/24/2015. Disclosure. Preventing Medication Errors in a Just Culture Environment. Blame Free Culture. Objectives.

PDR Electronic Library & Clinical Pharmacology Online:

a Foundation for Change

Certified Professional in Healthcare Information and Management Systems (CPHIMS) Renewal Guidelines and Application Revised March 01, 2011

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act.

University of Louisville Hospital PGY1 Pharmacy Residency Program Summary

Pharmacy Program Pre-Test

Minimum Qualifications for appointment of Teaching faculty in University and Colleges-Engineering and Technology Discipline.

Standardization of Technician Education Want it? Need it? Janet Teeters, M.S., R.Ph. Director of Accreditation Services ASHP

Megan Murphy-Menezes, Pharm.D., MSCR

DISTRICT OF COLUMBIA MUNICIPAL REGULATIONS FOR PHARMACY TECHNICIANS

NP CE Requirements. California California Nurse Practitioners must complete 30 hours of continuing nursing education every two years.

CME COORDINATOR / MEETING PLANNER TRAINING. June 4, 2013 MET Building, La Jolla

Northeast Ohio Medical University (NEOMED) Chair of Pharmaceutical Sciences Search

Preparing for the Medicare Part D Requirements for e-prescribing in Long-Term Care

2011 HeartCode ACLS Part 1 (Product # ) Frequently Asked Questions (FAQs)

Transcription:

PREVENTING MEDICATION ERRORS IN PHARMACY PRACTICE DR. SULLIVAN S SUPPLEMENTAL HANDOUT

PREVENTING MEDICATION ERRORS IN PHARMACY PRACTICE ACTIVITY DESCRIPTION Medications errors may occur more often than you think. Everyone in the pharmacy must have as a goal the prevention of medication errors. The goal of every pharmacist is to follow the five Rs : right drug, right patient, right dose, right time, and right route. This knowledge based program will give health care providers an understanding of how medication errors occur with an emphasis on preventing them from occurring in your pharmacy practice. This program has been APPROVED by the Florida Board of Pharmacy for Medication Errors. TARGET AUDIENCE The target audience for this activity is pharmacists and pharmacy technicians in hospital, community, and retail pharmacy settings. LEARNING OBJECTIVES After completing this activity, the pharmacist will be able to: Identify the real truths about medication error occurrence Describe the process of root cause analysis List the common pitfalls in root cause analysis Describe the methods to improve patient safety regarding medication error prevention Identify common medication error prevention and reduction techniques Define the process of failure mode and effects analysis (FMEA) Describe the application of failure mode and effect analysis using case examples to prevent medication errors Identify how medication reconciliation can improve patient safety ACCREDITATION PHARMACY PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. NURSING PharmCon, Inc. is approved by the California Board of Registered Nursing (Provider Number CEP 13649) and the Florida Board of Nursing (Provider Number 50-3515). Activities approved by the CA BRN and the FL BN are accepted by most State Boards of Nursing. CE hours provided by PharmCon, Inc. meet the ANCC criteria for formally approved continuing education hours. The ACPE is listed by the AANP as an acceptable, accredited continuing education organization for applicants seeking renewal through continuing education credit. For additional information, please visit http://www.nursecredentialing.org/renewalrequirements.aspx Universal Activity No.: 0798-0000-14-287-L03-P&T Credits: 2 contact hours (0.2 CEU) Release Date: March 1, 2014 Expiration Date: March 1, 2017 ACTIVITY TYPE Knowledge-Based Live Webinar After completing this activity, the pharmacy technician will be able to: List the most common types of medication errors Identify strategies to minimize the most common errors made by pharmacy technicians Describe root cause analysis 1

ABOUT THE AUTHOR Donnie Sullivan is a professor of pharmacy practice at Ohio Northern University. He received his B.S. in pharmacy from Ohio State University in 1990, his MS from Ohio State University in 1991, and his Ph.D. is Pharmacy Administration from Ohio State University in 1996. He has published several peer-reviewed articles and five consumer drug reference books. He has taught courses in pharmacy law, medication error prevention, and OTC products for 15 years. He has done more than 90 professional presentations on pharmacy law, medication error prevention techniques, and OTC products all across the U.S. He has been voted professor of the year by his students in 13 of his 14 years at Ohio Northern University. Donnie Sullivan, PhD Professor of Pharmacy Practice, Ohio Northern University FACULTY DISCLOSURE It is the policy of PharmCon, Inc. to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) and/or service(s) discussed in an educational activity. Donnie Sullivan reports no actual or potential conflict of interest in relation to this activity. Peer review of the material in this CE activity was conducted to assess and resolve potential conflict of interest. Reviewers unanimously found that the activity is fair balanced and lacks commercial bias. Please Note: PharmCon, Inc. does not view the existence of relationships as an implication of bias or that the value of the material is decreased. The content of the activity was planned to be balanced and objective. Occasionally, authors may express opinions that represent their own viewpoint. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient or pharmacy management. Conclusions drawn by participants should be derived from objective analysis of scientific data presented from this monograph and other unrelated sources. 2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20